Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedNov 18, 2025
DataAggregated Company Financials
Companies56
  • 7D-3.4%
  • 3M-12.0%
  • 1Y2.8%
  • YTD8.0%

The Pharma industry has been flat over the last week, but Bora Pharmaceuticals has lost 13%. As for the the longer term, the industry is up 6.5% over the past 12 months. As for the next few years, earnings are expected to grow by 145% per annum.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 19 Nov 2025NT$695.5bNT$117.0bNT$12.3b16.3x56.7x5.9x
Fri, 17 Oct 2025NT$794.3bNT$118.3bNT$9.6b15.8x82.6x6.7x
Sun, 14 Sep 2025NT$842.2bNT$118.4bNT$10.2b16.5x82.4x7.1x
Tue, 12 Aug 2025NT$690.2bNT$117.5bNT$12.5b17.3x55.4x5.9x
Thu, 10 Jul 2025NT$630.7bNT$116.0bNT$14.3b18.5x44.1x5.4x
Sat, 07 Jun 2025NT$631.0bNT$115.9bNT$14.3b19.1x44.2x5.4x
Mon, 05 May 2025NT$566.9bNT$113.3bNT$10.6b18.9x53.5x5x
Wed, 02 Apr 2025NT$588.8bNT$112.8bNT$10.8b18.3x54.4x5.2x
Fri, 28 Feb 2025NT$674.8bNT$109.4bNT$11.5b23.5x58.7x6.2x
Sun, 26 Jan 2025NT$612.0bNT$109.3bNT$11.4b21.7x53.5x5.6x
Tue, 24 Dec 2024NT$591.2bNT$109.3bNT$11.4b21.7x51.7x5.4x
Thu, 21 Nov 2024NT$632.2bNT$109.1bNT$11.5b23x55.1x5.8x
Sat, 19 Oct 2024NT$622.7bNT$104.7bNT$8.9b27x69.6x5.9x
Mon, 16 Sep 2024NT$630.8bNT$104.7bNT$8.9b25.1x70.5x6x
Wed, 14 Aug 2024NT$640.0bNT$101.4bNT$7.3b28.7x87.3x6.3x
Fri, 12 Jul 2024NT$681.6bNT$100.5bNT$6.8b31.8x99.8x6.8x
Sun, 09 Jun 2024NT$636.7bNT$100.4bNT$7.1b29.7x89.1x6.3x
Tue, 07 May 2024NT$618.1bNT$101.8bNT$9.3b25.1x66.1x6.1x
Thu, 04 Apr 2024NT$696.9bNT$101.5bNT$9.4b26.7x74.5x6.9x
Sat, 02 Mar 2024NT$657.1bNT$101.7bNT$8.3b23.6x79.5x6.5x
Mon, 29 Jan 2024NT$590.5bNT$101.9bNT$7.8b23.7x75.8x5.8x
Wed, 27 Dec 2023NT$576.9bNT$101.6bNT$7.6b23.5x75.6x5.7x
Fri, 24 Nov 2023NT$567.4bNT$101.6bNT$8.3b23.6x68.5x5.6x
Sun, 22 Oct 2023NT$521.7bNT$101.7bNT$9.6b20.2x54.2x5.1x
Tue, 19 Sep 2023NT$564.3bNT$101.7bNT$9.6b22.5x58.6x5.6x
Thu, 17 Aug 2023NT$546.0bNT$101.1bNT$9.1b20.6x60.3x5.4x
Sat, 15 Jul 2023NT$569.2bNT$98.7bNT$10.1b16.9x56.6x5.8x
Mon, 12 Jun 2023NT$588.0bNT$98.6bNT$10.1b17x58.5x6x
Wed, 10 May 2023NT$571.5bNT$92.1bNT$8.6b21.5x66.6x6.2x
Fri, 07 Apr 2023NT$582.4bNT$91.5bNT$8.7b20.8x67.3x6.4x
Sun, 05 Mar 2023NT$562.2bNT$84.7bNT$7.6b23.5x73.7x6.6x
Tue, 31 Jan 2023NT$486.6bNT$84.6bNT$7.9b20x61.7x5.7x
Thu, 29 Dec 2022NT$501.8bNT$84.6bNT$7.9b21.3x63.6x5.9x
Sat, 26 Nov 2022NT$476.9bNT$84.6bNT$7.9b16.3x60.5x5.6x
Price to Earnings Ratio

60.5x


Total Market Cap: NT$476.9bTotal Earnings: NT$7.9bTotal Revenue: NT$84.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 66x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 56.7x which is lower than its 3-year average PE of 66.0x.
  • The industry is trading close to its 3-year average PS ratio of 6.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 16% per year over the last three years.
  • Revenues for these companies have grown 11% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market-3.61%
Healthcare-3.45%
Pharma-3.40%
Pharma-3.40%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6919 Caliway BiopharmaceuticalsNT$134.508.5%
+NT$16.3b		150.5%PS5961.6x
1720 Standard Chemical & PharmaceuticalNT$62.705.4%
+NT$571.8m		-1.4%PE12.5x
6917 Andros PharmaceuticalsLtdNT$25.4021.5%
+NT$204.2m		55.8%n/a
4746 Formosa LaboratoriesNT$63.702.2%
+NT$168.4m		-19.5%PE31.8x
6817 Winston Medical SupplyNT$108.002.4%
+NT$46.0m		21.8%PE14.8x

Latest News

6620
NT$117.50
Handa Pharmaceuticals
7D
-3.3%
1Y
100.5%
6472
NT$513.00
Bora Pharmaceuticals
7D
-19.3%
1Y
-22.4%
4746
NT$63.70
Formosa Laboratories
7D
2.2%
1Y
-19.5%
4114
NT$31.60
Synmosa Biopharma
7D
-4.2%
1Y
0.2%
1795
NT$282.50
Lotus Pharmaceutical
7D
-1.9%
1Y
-1.9%
4123
NT$35.65
Center Laboratories
7D
-3.0%
1Y
-25.4%
1720
NT$62.70
Standard Chemical & Pharmaceutical
7D
5.4%
1Y
-1.4%
4743
NT$58.90
Oneness Biotech
7D
-5.0%
1Y
-44.7%
6785
NT$232.50
Alar Pharmaceuticals
7D
-10.2%
1Y
52.0%
6919
NT$134.50
Caliway Biopharmaceuticals
7D
8.5%
1Y
150.5%
1789
NT$17.00
ScinoPharm Taiwan
7D
-4.2%
1Y
-28.0%
6917
NT$25.40
Andros PharmaceuticalsLtd
7D
21.5%
1Y
55.8%
6935
NT$30.10
Prince Pharmaceutical
7D
1.2%
1Y
36.2%
6817
NT$108.00
Winston Medical Supply
7D
2.4%
1Y
21.8%